Analyzing device-to-device communication performance with amplify-and-forward relaying amid co-channel interference
Computer and Telecommunication Engineering · 2024
DOI: 10.54517/cte2327 ↗Kurz gefasst
Fachartikel in der Zeitschrift Computer and Telecommunication Engineering, 2024. Verfasst von Huu Quy Tran. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Currently, the pressing issue of spectrum limitation, driven by the increasing demand for wireless communication services, has led to the challenge of co-channel interference (CCI) due to the reuse of frequencies in wireless networks. To address this, non-orthogonal multiple access (NOMA) has emerged as a solution. This report conducts a thorough evaluation of NOMA’s system performance over independent and non-identical Rayleigh fading channels in device-to-device (D2D) communications networks, where CCI is significant. The analysis includes examining the probability density function (PDF) and cumulative distribution function (CDF) of the upper SINR threshold. Communication channels are defined as independent and non-identical Rayleigh fading channels, and probability expressions are formulated to assess system failure likelihood for two users. Additionally, Monte-Carlo simulations are conducted to validate the proposed theoretical mathematical expressions.
Zitieren
APA
Tran, H. Q. (2024). Analyzing device-to-device communication performance with amplify-and-forward relaying amid co-channel interference. Computer and Telecommunication Engineering. https://doi.org/10.54517/cte2327
Vancouver
Tran HQ. Analyzing device-to-device communication performance with amplify-and-forward relaying amid co-channel interference. Computer and Telecommunication Engineering. 2024. doi:10.54517/cte2327
BibTeX
@article{Tran2024,
author = {Tran, Huu Quy},
title = {Analyzing device-to-device communication performance with amplify-and-forward relaying amid co-channel interference},
journal = {Computer and Telecommunication Engineering},
year = {2024},
doi = {10.54517/cte2327}
}
EUVIMED